| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Articles |
The World Health Organization estimates that 28-30 million people have been infected with human immunodeficiency virus (HIV). Although many important questions remain, much has been learned regarding the biology of heterosexual HIV transmission. For example, most sexual transmission of HIV is probably mediated by cell-free virus. Langerhans cells in the vaginal epithelium and dendritic cells or macrophages in the lamina propria are the most likely target cells in HIV transmission. Although there is restriction in the genotypes of viruses that are sexually transmitted, the common phenotypic characteristic of these viruses does not appear to be related to in vitro measures of tropism but rather to the relatively high in vivo replicative fitness of the transmitted viral variants. Clearly, host factors such as the amount of HIV-1 co-receptor expression on host cells and the presence of ulcerative sexually transmitted diseases affect the susceptibility of an individual to HIV infection. The growing body of information has increased the likelihood that a vaccine capable of preventing HIV-1 infection after exposure during sexual activity will be developed in the foreseeable future.
This article has been cited by other articles:
![]() |
T. van Montfort, A. A. M. Thomas, G. Pollakis, and W. A. Paxton Dendritic Cells Preferentially Transfer CXCR4-Using Human Immunodeficiency Virus Type 1 Variants to CD4+ T Lymphocytes in trans J. Virol., August 15, 2008; 82(16): 7886 - 7896. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Kish, L. R. Budgeon, P. A. Welsh, and M. K. Howett Immunological Characterization of Human Vaginal Xenografts in Immunocompromised Mice : Development of a Small Animal Model for the Study of Human Immunodeficiency Virus-1 Infection Am. J. Pathol., December 1, 2001; 159(6): 2331 - 2345. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kawamura, S. S. Cohen, D. L. Borris, E. A. Aquilino, S. Glushakova, L. B. Margolis, J. M. Orenstein, R. E. Offord, A. R. Neurath, and A. Blauvelt Candidate Microbicides Block HIV-1 Infection of Human Immature Langerhans Cells within Epithelial Tissue Explants J. Exp. Med., November 20, 2000; 192(10): 1491 - 1500. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Otten, D. K. Smith, D. R. Adams, J. K. Pullium, E. Jackson, C. N. Kim, H. Jaffe, R. Janssen, S. Butera, and T. M. Folks Efficacy of Postexposure Prophylaxis after Intravaginal Exposure of Pig-Tailed Macaques to a Human-Derived Retrovirus (Human Immunodeficiency Virus Type 2) J. Virol., October 15, 2000; 74(20): 9771 - 9775. [Abstract] [Full Text] |
||||
![]() |
J. Hu, M. B. Gardner, and C. J. Miller Simian Immunodeficiency Virus Rapidly Penetrates the Cervicovaginal Mucosa after Intravaginal Inoculation and Infects Intraepithelial Dendritic Cells J. Virol., July 1, 2000; 74(13): 6087 - 6095. [Abstract] [Full Text] |
||||
![]() |
P. Greenhead, P. Hayes, P. S. Watts, K. G. Laing, G. E. Griffin, and R. J. Shattock Parameters of Human Immunodeficiency Virus Infection of Human Cervical Tissue and Inhibition by Vaginal Virucides J. Virol., June 15, 2000; 74(12): 5577 - 5586. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |